Search results
Results From The WOW.Com Content Network
The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, [2] the Sinopharm COVID-19 vaccine, [3] or BIBP vaccine, [3][4][5] is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm 's Beijing Institute of Biological Products (sometimes written as Beijing Bio-Institute of Biological Products, [6] resulting in the two ...
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
Sinopharm CNBG COVID-19 vaccine Vaccine description Target SARS-CoV-2 Vaccine type Protein subunit Clinical data Routes of administration Intramuscular Legal status Legal status Full list of Sinopharm NVSI authorizations Identifiers CAS Number 2503126-65-4 Part of a series on the COVID-19 pandemic Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an ...
China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise.The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group (SEHK: 1099, via a 51–49 joint venture, Sinopharm Industrial Investment, with Fosun Pharmaceutical), China Traditional Chinese Medicine [] (SEHK: 570, mostly via ...
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, [ 2 ][ 3 ] is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results show that the vaccine is 72.8% effective against symptomatic cases and 100% against severe cases (26 cases in vaccinated group vs. 95 cases in placebo group). [ 4 ]
Sinopharm Group. Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock ...
CoronaVac, also known as the Sinovac COVID-19 vaccine, [4] was a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. [5][6] It was phase III clinically trialled in Brazil, [7] Chile, [8] Indonesia, [9] the Philippines, [10] and Turkey [11] and relies on traditional technology similar to other inactivated ...
56.84% has been fully vaccinated. The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.